UNS
Click for more information
0.00% 0.5¢ unilife corporation

Betrixaban, keep an eye on this new drug could be the...

  1. oslo
    5,687 Posts.
    clock Created with Sketch.
    29/01/16
    23:28
    Post #: 16901345
    Betrixaban, keep an eye on this new drug could be the blockbuster. Not good news for Sanofi if this gets FDA approved this year.
    Last edited by oslo: 29/01/16
    UNS Price at posting: 22.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.